Global Kaposi Sarcoma Treatment Market: Trends, Size, Growth, Opportunity, and Forecast to 2022-2028
The malignant tumour illness known as kaposi sarcoma is most commonly found in the skin, mucous membranes, lymph nodes, and other organs. Skin lesions, lesions in the mucous membranes lining the mouth, nose, and throat, lesions in the lymph nodes, and lesions in other organs all develop as a result of kaposi sarcoma. All individuals with Kaposi Sarcoma Treatment Market have human herpesvirus-8 (HHV-8) in high concentrations in their lesions. In contrast, HHV-8, a heterovirus that aids in the growth of Kaposi sarcoma, is extremely contagious among people whose immune systems have been compromised by Acquired Immune Deficiency Syndrome (AIDS) illness or medications given after organ transplant surgery. Immunosuppressive medications are given to organ transplant recipients in order to stop their bodies from rejecting the graft, however this makes them more vulnerable to Kaposi sarcoma associated herpesvirus (KSHV) infection.
